Intermittent Montelukast Compared to Placebo in Children Wheeze

by Himabindu Venkatakrishnan on  September 9, 2014 at 8:15 PM Child Health News
RSS Email Print This Page Comment
Font : A-A+

A study compared effectiveness of intermittent montelukast with placebo in reducing wheezing episodes in 1358 children aged 10 months to 5 years and whether genotype determined the patient outcome.
 Intermittent Montelukast Compared to Placebo in Children Wheeze
Intermittent Montelukast Compared to Placebo in Children Wheeze

Study authors found that intermittent montelukast only reduced wheezing episodes in children with arachidonate 5-lipoxygenase (ALOX5) gene promoter 5/5, a gene that has previously been associated with a better response to montelukast in adults. There was no correlation with reduced wheezing episodes for children without this specific genotype. Therefore the researchers call for more research into the effects of montelukast in children with this genetic subtype.



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Asthma Height and Weight-Kids Placebo Effects: Rare Insights Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive